Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1024–1031. doi: 10.5588/ijtld.20.0048

Table 2:

Primary Outcomes

Outcomes BLIX cohort N=151 n (%) Historical control cohort N=105 n (%)

Treatment success 96 (63.6) 33 (31.4)
Cured 95 (62.9) 27 (25.7)
Completed treatment 1 (0.7) 6 (5.7)
Loss to retention in care 22 (14.6) 17 (16.2)
Treatment failure 7 (4.6) 12 (11.4)
Death* 26 (17.2) 43 (41.0)
*

p<0.001